ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

May 2, 2008

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Congress Passes HHS Appropriations, Includes $9 Billion for NIH, $575 Million Delayed Funding

November 15, 1991

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004

Medicare Cuts Payments To Physicians By 21%. House Bill Would Mandate Medicare Coverage Of CT Scans For Colorectal Cancer Screening

June 4, 2010